Keyphrases
Antithymocyte Globulin
50%
Bone Marrow
25%
Busulfan
50%
Campath
50%
Chimerism
25%
Clinical Conditions
25%
Conditioning Regimen
25%
Donor Cells
25%
Donor Source
25%
Engraftment
25%
Female Donors
25%
Fludarabine
100%
Graft-versus-host Disease (GvHD)
50%
Haploidentical Peripheral Blood Stem Cell Transplantation
100%
HLA Matching
25%
Hurler Syndrome
100%
Matched Sibling
25%
Monoclonal Antibody
25%
Monophosphate
25%
Neurologic Signs
25%
Peripheral Blood
25%
Polymerase Chain Reaction
25%
Reconstitution
25%
Repeat Analysis
25%
Restriction Fragment Length Polymorphism
25%
T Cell Depletion
50%
Tandem Repeats
25%
Therapeutic Potential
25%
Total Body Irradiation
50%
Transplant Complications
25%
Transplantation Conditioning
25%
Biochemistry, Genetics and Molecular Biology
Alemtuzumab
50%
Busulfan
50%
Chimera
25%
Conditioning
50%
Cytogenetics
25%
Fludarabine
100%
Globulin
50%
Host
50%
Hurler Syndrome
100%
Leporidae
25%
Low Drug Dose
25%
Monoclonal Antibody
25%
Peripheral Blood Stem Cell Transplantation
100%
Polymerase Chain Reaction
25%
Restriction Fragment Length Polymorphism
25%
Single Drug Dose
25%
T Cell
75%
T Cell Depletion
25%
Tandem Repeat
25%
Immunology and Microbiology
Alemtuzumab
50%
Chimera
25%
Conditioning
50%
Engraftment
25%
Graft-Versus-Host Disease
50%
Leporidae
25%
Low Drug Dose
25%
Monoclonal Antibody
25%
Peripheral Blood Stem Cell Transplantation
100%
Polymerase Chain Reaction
25%
Restriction Fragment Length Polymorphism
25%
T Cell
75%
T Cell Depletion
25%
Tandem Repeat
25%
Transplant Procedure
50%
Pharmacology, Toxicology and Pharmaceutical Science
Alemtuzumab
50%
Busulfan
50%
Fludarabine
100%
Fludarabine Phosphate
25%
Globulin
50%
Graft Versus Host Reaction
50%
Hurler Syndrome
100%
Leporidae
25%
Monoclonal Antibody
25%
Neurologic Disease
25%